Long-Term Side Effects of Immunotherapy for Melanoma
Part of Cancer, Skin clinical trials.
This study looks at long-term side effects in people who received immunotherapy for advanced melanoma and have had their cancer controlled for at least 3 years. Researchers want to understand how these treatments affect patients years later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with melanoma (a type of skin cancer).
- You are 18 years old or older.
- You received immunotherapy (drugs like Keytruda, Opdivo, or Yervoy) for advanced melanoma between January 2005 and December 2020.
- Your melanoma has been stable or improved for at least 3 years since starting that immunotherapy.
- You do not have any other active cancer that is being treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of three drugs (relatlimab, ipilimumab, and nivolumab) as a first treatment for advanced melanoma that cannot be removed by surgery. All participants will receive the drug combination, and the study will look at safety and how well it works.
This study looks at whether physical activity can help reduce side effects from immunotherapy in people with melanoma. You may join if you are starting a certain type of immunotherapy for melanoma.
This trial studies the timing of a standard immunotherapy combination for advanced melanoma that cannot be removed by surgery or has spread. It aims to understand how timing affects treatment results.
This study checks on the long-term health of adults with melanoma who took part in a previous treatment study. It aims to see how participants are doing over time after receiving the new therapy.
This study looks at how side effects happen in people receiving immune checkpoint inhibitor immunotherapy for solid cancers. It uses multiple types of tests to better understand these toxicities and may help improve safety and care in the future.
This study looks at how people with advanced melanoma (a serious skin cancer) feel during treatment with immunotherapy. It aims to better understand the symptoms they experience, so doctors can help manage them.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.